Lenalidomide Melphalan and Prednisone Versus High Dose Melphalan in Newly Diagnosed Multiple Myeloma Patients

Clinical trial NCT00551928 · COMPLETED

Trial details

NCT number: NCT00551928
Sponsor: Fondazione EMN Italy Onlus
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Myeloma Newly Diagnosed Patients

Start date: 2007-06-01
Primary completion: 2022-06-01
Enrollment: 402

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.